Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Ellen McLaughlin

InveniAI® to collaborate with GlaxoSmithKline

InveniAI® has announced a strategic collaboration with GlaxoSmithKline Consumer Healthcare. GlaxoSmithKline Consumer Healthcare will leverage AlphaMeld®, InveniAI’s  AI and ML platform that empowers internal teams to...

| By Ellen McLaughlin

Yale investigates a rare degenerative disease

Yale pharmacology professor Barbara Ehrlich and her team have uncovered a mechanism driving a rare, lethal disease called Wolfram Syndrome and also a potential treatment....

| By Ellen McLaughlin

UConn researchers solve vexing vaccine problem

Researchers at the UConn Center of Excellence in Vaccine Research have made a breakthrough in vaccine development for a common and difficult to treat pneumonia-causing pathogen...

| By Ellen McLaughlin

Blavatnik Fund awards $2.6 million to Yale faculty

The Office of Cooperative Research at Yale University has announced the 2020 Blavatnik Award recipients. The Blavatnik Fund for Innovation at Yale supports Yale faculty in the...

| By Ellen McLaughlin

Enrich Therapeutics secures funding from CI

Enrich Therapeutics has successfully closed $320k in seed funding. The round was led by Connecticut Innovations. The funding will support the ongoing development of Enrich’s proprietary...

| By Ellen McLaughlin

Assembly and BeiGene collaborate re hepatitis B

Assembly Biosciences and BeiGene, Ltd. report that the companies have entered into a collaboration in China for Assembly’s portfolio of three clinical-stage core inhibitor candidates...

| By Ellen McLaughlin

Pfizer, preparing COVID-19 vaccine, has CT presence

Pfizer and BioNTech report the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to begin delivering 300...

| By Ellen McLaughlin

Pfizer & BioNTech report plans for COVID vaccine

Pfizer and BioNTech report the execution of an agreement with the U.S. Department of Health and Human Services and the Department of Defense to begin delivering 300...